Key facts
- Valencia Technologies’s last known valuation is $63.4M (Jun 2015).
- It has raised $63.3M across 9 recorded rounds; the latest was Seed Round ($4.2M) in Nov 2019.
- Valencia Technologies has filed 11 Form Ds with the SEC since 2013, most recently Mar 2020 ($1.9M sold to 13 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 9 rounds
- ·Watchlist + deal alerts for Valencia Technologies
Funding rounds
9 roundsAbout Valencia Technologies
Developer of a coin-sized fully-implanted neurostimulator designed to stimulate nerves in the periphery to ameliorate chronic conditions. The company's neurostimulator is placed under the skin in the forearm to provide automatic stimulation on the tibial nerve that reduces the risk of cardiovascular disease, bladder dysfunction, and stroke, enabling patients to get treatment for urge urinary incontinence and other chronic diseases.
- Sector
- Healthcare
- HQ
- Santa Clarita, CA, United States
- Founded
- 2011
- Employees
- 106
- Website
- valenciatechnologies.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Valencia Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Valencia Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Valencia Technologies in its N-PORT filings yet. We sweep new filings monthly.